Public Alert No. 0034/2020- Malaysian Authority Ban Bb Glow Soul Cream For Containing Harmful Substances
, The National Agency for Food and Drug Administration and Control has been informed that the Malaysian National Pharmaceutical Regulatory Agency (NPRA) has banned the use of BB Glow Soul Cream. The product was found to contain hydroquinone and tretinoin which are injurious to health, and can cause redness to skin, hypersensitive skin as well […]
Public Alert No. 033/2020- Caution Against Consumption Of Swiss Alpine Green Tea
, The National Agency for Food and Drug Administration and Control has been informed that the China Food and Drug Administration (CFDA) has cautioned against regular consumption of Swiss Alpine Green Tea manufactured by Bio Suisse, Switzerland. This warning is due to high phenolphthalein and hydro-alcoholic content in the product that can cause gastrointestinal irritation, […]
Public Alert No: 0032/2020 – Alert on Benadryl (Diphenhydramine)
, The National Agency for Food and Drug Administration and Control (NAFDAC) hereby warns the general public that taking more than the recommended doses of the popular over-the-counter (OTC) allergy medicine diphenhydramine (Benadryl) can lead to serious heart problems, seizures, coma, or even death. The Benadryl Challenge is allegedly making the rounds on TikTok social media application, […]
Public Alert No. 0031/2020-Alert on Fake Hydroxychloroquine Medication in Circulation
, The National Agency for Food and Drug Administration and Control has been informed that the Chilean Institute of Public Health has issued a warning on the circulation of fake hydroxychloroquine sulphate-based medication tablets, Reumazine 200mg with Lot Number 0307620/F18705 and expiry date of March, 2022. The fake Reumazine 200mg is already in circulation in […]
Public Alert No. 0030/2020 – Warning on use of Tafrodol Manufactured by Deep Pharmaceutical, India
, The National Agency for Food and Drug Administration and Control (NAFDAC) alerts the members of the public against the use of a drug marketed on the internet under the brand name Tafrodol by Deep Pharmaceutical, Mumbai, Maharashtra, India. The active ingredients for Tafrodol declared by the manufacturer are Tapentadol Hcl 100mg and Carisoprodol 125mg […]
Public Alert No. 021/2020-The Protein Shoppe recalls Red-E Male Enhancement Tablets Due to the Presence of Undeclared Sildenafil
, The National Agency for Food and Drug Administration and Control has been informed that the Protein Shoppe, LLC has announced a voluntary recall of all lots of Red-E Male Enhancement Tablets. The recall was initiated after an FDA analysis found that the product contains undeclared sildenafil, a Phosphodiesterase-5 (PDE-5) inhibitor that is used in […]
Public Alert No. 028/2020- Boots Company PLC Recalls Boots Dermacare 1% w/w Hydrocortisone Ointment, EL (20) A/47 (Batch Number: IDD) due to the presence of Pseudomonas aeruginosa
, The National Agency for Food and Drug Administration and Control has been informed by the United Kingdom’s (UK) Medicine and Healthcare Product Regulatory Agency (MHRA) that Boots Company PLC has recalled Boots Dermacare 1% w/w Hydrocortisone Ointment, EL (20) A/47 (Batch Number: IDD) due to the presence of Pseudomonas aeruginosa. Boots Dermacare 1% w/w […]
Public Alert No. 027/2020-Distribution and Sale of Unregistered Daonil 5mg Tablets
, The National Agency for Food and Drug Administration and Control has been informed by Sanofi-Adventis Nigeria Limited on the distribution and sale of unregistered Daonil 5mg tablets (60×10) in Nigeria. Sanofi Adventis Nigeria is the marketing authorization holder for Daonil 5mg tablets (10×10) in Nigeria with NAFDAC registration number (NRN) 04-0744. The details of […]
Public Alert No: 026/2020-Alert on Petazone (Dexamethasone Injection) Batch Number 190314 Due to Unsatisfactory Report of Laboratory Analysis
, The National Agency for Food and Drug Administration and Control (NAFDAC) following an investigation on Petazone (Dexamethasone Injection) batch number 190314 sampled and analyzed the product. The result of laboratory analysis was observed to be unsatisfactory. The report of the analysis on the product established that the affected batch of the product failed sterility […]
Opening Address By Professor Mojisola Christianah Adeyeye Adeyeye At The Virtual Launch Of The Med Safety Mobile App For Adverse Drug Reactions Reporting In Nigeria
Keynote Speech By Prof. Adeyeye C. M Director General NAFDAC Virtual Launch Of The Med Safety Mobile App For Adverse Drug Reactions Reporting In Nigeria NAFDAC Head Quarters, Abuja. 4th November, 2020. The Honourable Minister of Health, Federal Republic of Nigeria, The Permanent Secretary, Federal Ministry of Health The Chairman, National Drug Safety Advisory Committee […]
